AMGEN INC — Director's Dealing 2012

Mar 12, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-03-08

Reporting Person: BALTIMORE DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-08	Common Stock	M	5000	$58.61	Acquired	33509	Direct
2012-03-08	Common Stock	F	4378	$66.95	Disposed	29131	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-08	Nqso (Right to Buy)	$58.61	M	5000	Disposed	2012-03-15	Common Stock (5000)	Direct